click below
click below
Normal Size Small Size show me how
BDK ID #3-4
Basic Drug Knowledge Infectious Diseases Page #3-4
| Generic Name | Brand Name | Classification | Pharmacologic Category | Common Indications | Activity Against |
|---|---|---|---|---|---|
| Clindamycin (PO, IV) | Cleocin | Lincosamide Antibiotic | Skin & Soft Tissue Infection (SSTI), Pharyngitis | MRSA (Methicillin-Resistant Staphylococcus Aureus) | |
| Sulfamethoxazole & Trimethoprim (PO, IV) | Bactrim, Bactrim DS | Sulfonamide Antibiotic | Skin & Soft Tissue Infection (SSTI), Cystitis, Pyelonephritis, Opportunistic Infection Prophylaxis | MRSA (Methicillin-Resistant Staphylococcus Aureus), Enterobacteriaceae | |
| Nitrofurantoin (PO) | Macrobid | Urinary Antibiotic | Cystitis | Escherichia Coli | |
| Fosfomycin (PO) | Monurol | Urinary Antibiotic | Cystitis | Escherichia Coli | |
| Tobramycin (IV, Inhaled) | Tobi (Inhaled) | Aminoglycoside Antibiotic | Hospital-Acquired Pneumonia (HAP), Cystic Fibrosis (Nebulized Only) | Escherichia Coli, Pseudomonas Aeruginosa | |
| Vancomycin (IV, PO) | Vancocin | Glycopeptide Antibiotic | IV: Skin & Soft Tissue Infection (SSTI), Hospital-Acquired Pneumonia (HAP), Meningitis, Endocarditis, Catheter-Related Blood Stream Infection (CRBSI) PO: Clostridioides Difficile Infection (CDI) | MRSA (Methicillin-Resistant Staphylococcus Aureus), Clostridioides Difficile (PO Only) | |
| Metronidazole (PO, IV) | Flagyl | Antibiotic | Anaerobic Infections, Clostridioides Difficile Infection (CDI) | Bacteroides Species, Clostridioides Difficile | |
| Mupirocin (Topical) | Bactroban | Antibiotic | Methicillin-Resistant Staphylococcus Aureus (MRSA) Decolonization | ||
| Neomycin + Polymyxin B + Bacitracin (Topical, Ophthalmic) | Topical: Neosporin Ophthalmic: Neo-Polycin | Neosporin: OTC | Topical Antibiotic | Topical Infection Prevention, Ocular Infections | |
| Terbinafine (PO, Topical) | Lamisil | Topical: OTC | Allylamine Antifungal | Onychomycosis | |
| Fluconazole (PO, IV) | Diflucan | Azole Antifungal | Vulvovaginal Candidiasis, Oropharyngeal Candidiasis, Invasive Candidiasis | ||
| Ketoconazole (PO, Topical) | Nizoral | Topical: OTC | Azole Antifungal | Tinea Infections | |
| Nystatin (PO) | --- | Polyene Antifungal | Oropharyngeal Candidiasis | ||
| Nystatin (Topical) | Nystop | Polyene Antifungal | Cutaneous & Mucocutaneous Fungal Infections | ||
| Micafungin (IV) | Mycamine | Echinocandin Antifungal | Invasive Candidiasis | ||
| Betamethasone & Clotrimazole (Topical) | Lotrisone | Glucocorticoid & Azole Antifungal | Cutaneous Fungal Infections | ||
| Oseltamivir (PO) | Tamiflu | Neuraminidase Inhibitor Antiviral | Influenza | ||
| Acyclovir (PO, IV) | Zovirax | Antiviral | Herpes Simplex Virus | ||
| Valacyclovir (PO) | Valtrex | Antiviral | Herpes Simplex Virus | ||
| Nirmatrelvir + Ritonavir (PO) | Paxlovid | Antiviral | COVID-19 | ||
| Remdesivir (IV) | Veklury | Antiviral | COVID-19 | ||
| Emtricitabine + Tenofovir Disoproxil Fumarate (PO) | Truvada | Nucleoside/Nucleotide Reverse Transcriptase Inhibitor (NRTI) | Human Immunodeficiency Virus (HIV) Infection, Preexposure Prophylaxis (PreP), Postexposure Prophylaxis (PEP) | ||
| Emtricitabine (NRTI) + Tenofovir Alafenamide (NRTI) + Bictegravir (INSTI) (PO) | Biktarvy | Nucleoside/Nucleotide Reverse Transcriptase Inhibitor (NRTI) & Integrase Strand Transfer Inhibitor (INSTI) | Human Immunodeficiency Virus (HIV) Infection |